Page last updated: 2024-08-21

reticulin and Leukemia, Myelomonocytic, Chronic

reticulin has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Garcia-Manero, G; Gur, HD; Kanagal-Shamanna, R; Kantarjian, H; Khogeer, H; Khoury, JD; Loghavi, S; Medeiros, LJ; Pierce, S; Quesada, A; Routbort, M	1

Other Studies

1 other study(ies) available for reticulin and Leukemia, Myelomonocytic, Chronic

Article	Year
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations. The American journal of surgical pathology, 2018, Volume: 42, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Proliferation; Female; Genetic Predisposition to Disease; Humans; Janus Kinase 2; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Mutation; Mutation Rate; Phenotype; Primary Myelofibrosis; Prognosis; Reticulin; Retrospective Studies; Tumor Suppressor Protein p53; Young Adult	2018

Article

Year

Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.

The American journal of surgical pathology, 2018, Volume: 42, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Proliferation; Female; Genetic Predisposition to Disease; Humans; Janus Kinase 2; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Mutation; Mutation Rate; Phenotype; Primary Myelofibrosis; Prognosis; Reticulin; Retrospective Studies; Tumor Suppressor Protein p53; Young Adult

2018